Literature DB >> 15138641

[Inhalation combination therapy in chronic obstructive lung disease. TRISTAN-study].

W Seeger1, R Schulz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15138641     DOI： 10.1007/s00108-004-1177-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  3 in total

1.  Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease.

Authors:  Donald A Mahler; Patrick Wire; Donald Horstman; Chai-Ni Chang; Julie Yates; Tracy Fischer; Tushar Shah
Journal:  Am J Respir Crit Care Med       Date:  2002-10-15       Impact factor: 21.405

2.  The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.

Authors:  Nicola A Hanania; Patrick Darken; Donald Horstman; Colin Reisner; Benjamin Lee; Suzanne Davis; Tushar Shah
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

3.  Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease.

Authors:  W Szafranski; A Cukier; A Ramirez; G Menga; R Sansores; S Nahabedian; S Peterson; H Olsson
Journal:  Eur Respir J       Date:  2003-01       Impact factor: 16.671
  3 in total
  8 in total

Review 1.  Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Authors:  Sally Spencer; Charlotta Karner; Christopher J Cates; David J Evans
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

Review 2.  Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Authors:  Luis Javier Nannini; Toby J Lasserson; Phillippa Poole
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

Review 3.  Combined corticosteroid and long-acting beta₂-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease.

Authors:  Luis Javier Nannini; Phillippa Poole; Stephen J Milan; Rebecca Holmes; Rebecca Normansell
Journal:  Cochrane Database Syst Rev       Date:  2013-11-10

Review 4.  Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease.

Authors:  L J Nannini; C J Cates; T J Lasserson; P Poole
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

Review 5.  Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease.

Authors:  L Nannini; C J Cates; T J Lasserson; P Poole
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

Review 6.  Inhaled corticosteroids for stable chronic obstructive pulmonary disease.

Authors:  Ian A Yang; Melissa S Clarke; Esther H A Sim; Kwun M Fong
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

Review 7.  Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease.

Authors:  Kayleigh M Kew; Alieksei Seniukovich
Journal:  Cochrane Database Syst Rev       Date:  2014-03-10

Review 8.  Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease.

Authors:  Luis Javier Nannini; Phillippa Poole; Stephen J Milan; Annabel Kesterton
Journal:  Cochrane Database Syst Rev       Date:  2013-08-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.